Virtus Lifesci Biotech Etf Analysis
| BBP Etf | USD 62.66 0.71 1.15% |
Virtus LifeSci Biotech is fairly valued with Real Value of 62.4 and Hype Value of 62.68. The main objective of Virtus LifeSci etf analysis is to determine its intrinsic value, which is an estimate of what Virtus LifeSci Biotech is worth, separate from its market price. There are two main types of Virtus Etf analysis: fundamental analysis and technical analysis.
The Virtus LifeSci etf is traded in the USA on NYSE ARCA Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Virtus |
Virtus Etf Analysis Notes
The fund generated five year return of 12.0%. Virtus LifeSci Biotech holds 98.73% of assets under management (AUM) in equities. Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States. For more info on Virtus LifeSci Biotech please contact the company at NA.Virtus LifeSci Biotech Investment Alerts
| The fund holds 98.73% of its assets under management (AUM) in equities |
Virtus Market Capitalization
The company currently falls under '' category with a total capitalization of 0. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Virtus LifeSci's market, we take the total number of its shares issued and multiply it by Virtus LifeSci's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Virtus LifeSci Biotech invests in 61 different instruments across multiple market segments that include assets with varying market capitalizations.Management Efficiency
Virtus LifeSci's management efficiency ratios could be used to measure how well Virtus LifeSci manages its routine affairs as well as how well it operates its assets and liabilities.The analysis of Virtus LifeSci's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Virtus LifeSci's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Virtus Etf analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Returns 3 Y 8.11 | Returns 5 Y 11.77 | Returns 1 Y 31.21 | Total Assets 22 M | Returns YTD 7.86 |
Top Virtus LifeSci Biotech Etf Constituents
| LGND | Ligand Pharmaceuticals Incorporated | Stock | |
| IONS | Ionis Pharmaceuticals | Stock | |
| CLVS | Clovis Oncology | Stock | |
| PBYI | Puma Biotechnology | Stock | |
| ICPT | Intercept Pharmaceuticals | Stock | |
| SAGE | Sage Therapeutic | Stock | |
| BPMC | Blueprint Medicines Corp | Stock | |
| UTHR | United Therapeutics | Stock | |
| ACAD | ACADIA Pharmaceuticals | Stock | |
| PTCT | PTC Therapeutics | Stock | |
| RDUS | Schnitzer Steel Industries | Stock | |
| NBIX | Neurocrine Biosciences | Stock | |
| KPTI | Karyopharm Therapeutics | Stock | |
| ALNY | Alnylam Pharmaceuticals | Stock | |
| REGN | Regeneron Pharmaceuticals | Stock | |
| IRWD | Ironwood Pharmaceuticals | Stock | |
| AGIO | Agios Pharm | Stock | |
| ITCI | Intracellular Th | Stock | |
| INSM | Insmed Inc | Stock | |
| SGEN | Seagen Inc | Stock |
Institutional Etf Holders for Virtus LifeSci
Have you ever been surprised when a price of an equity instrument such as Virtus LifeSci is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Virtus LifeSci Biotech backward and forwards among themselves. Virtus LifeSci's institutional investor refers to the entity that pools money to purchase Virtus LifeSci's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Note, although Virtus LifeSci's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses. Technical Drivers
As of the 6th of October, Virtus LifeSci has the Coefficient Of Variation of 1080.44, risk adjusted performance of 0.0794, and Semi Deviation of 1.33. Virtus LifeSci technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the etf's future prices.Virtus LifeSci Biotech Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Virtus LifeSci middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Virtus LifeSci Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Virtus LifeSci Outstanding Bonds
Virtus LifeSci issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Virtus LifeSci Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Virtus bonds can be classified according to their maturity, which is the date when Virtus LifeSci Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Virtus LifeSci Predictive Daily Indicators
Virtus LifeSci intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Virtus LifeSci etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Virtus LifeSci Forecast Models
Virtus LifeSci's time-series forecasting models are one of many Virtus LifeSci's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Virtus LifeSci's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Virtus Etf Analysis
Etf analysis is the technique used by a trader or investor to examine and evaluate how Virtus LifeSci prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Virtus shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as Virtus LifeSci. By using and applying Virtus Etf analysis, traders can create a robust methodology for identifying Virtus entry and exit points for their positions.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our etf analysis tools, you can find out how much better you can do when adding Virtus LifeSci to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Additional Information and Resources on Investing in Virtus Etf
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.